Never Run Validation Batches Without Predefined GMP Protocols

Only Execute Validation Batches with Predefined, QA-Approved Protocols

Remember: GMP mandates that all validation batches be conducted under predefined and approved protocols—unplanned validation work is strictly prohibited.

Why This Matters in GMP

Validation batches demonstrate that a manufacturing process consistently produces products meeting predetermined specifications. Running validation batches without a formal protocol undermines the credibility of data, limits traceability, and fails to meet regulatory expectations. These protocols must outline objectives, acceptance criteria, sampling plans, and data analysis methodology. Without predefined documentation, validation lacks scientific rigor, making the process vulnerable to errors, bias, or misinterpretation. It also prevents QA oversight and jeopardizes the product’s regulatory approval status.

Also Read: Do Not Store Clean and Dirty Garments Together in GMP Facilities

Regulatory and Compliance Implications

FDA 21 CFR Part 211.100(a) requires written procedures for production and process control. EU GMP Annex 15 defines validation principles and mandates approval of protocols before execution. WHO GMP and Schedule M reinforce the need for formal, pre-approved validation documentation. Inspectors examine protocol content, QA sign-off, deviation handling, and statistical conclusions. Conducting validation activities without documented approval may result in data rejection, audit failures, or regulatory penalties.

Implementation Best Practices

Develop validation protocols with detailed scope, acceptance criteria, process steps, and risk analysis.
Obtain cross-functional review and formal QA

approval prior to initiation.

Record all execution steps and data in real-time with deviation reporting and QA oversight.

Use a change control system to initiate validation linked to process modifications or new equipment.

Train staff on protocol adherence and the importance of documentation integrity during validation runs.

Regulatory References

FDA 21 CFR Part 211.100 – Written Procedures and Process Control
EU GMP Annex 15 – Qualification and Validation Requirements
WHO GMP – Validation and Protocol-Driven Manufacturing
Schedule M – Process Validation Documentation